
    
      This is a randomized, open-label, multicenter Phase 3 study in adult participants with
      histologically confirmed, locally advanced or metastatic (Stage IIIB or IV), NSCLC (squamous
      or non-squamous) who have disease progression during or after a platinum-containing regimen.
    
  